RxDoctor Payments Data

Anuj Sharma, DO

Physical Medicine & Rehabilitation · Ocala, FLNPI 1881673507

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 282 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 23.3% — the pattern of someone who eats at a lot of different presentations. Among physical medicine & rehabilitation clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,360in general payments, 2019–2025

Across 282 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Pfizer$988
  • Collegium Pharmaceutical, Inc.$800
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$573
  • Biohaven Pharmaceutical Holding Company Ltd.$251
  • Protega Pharmaceutials Inc$230
  • plus $1K from 28 others

What the payments were for

  • Food & beverage$5,360100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,360 in reported general payments places this provider in the 90th percentile of 618 physical medicine & rehabilitation providers in Florida.

See all physical medicine & rehabilitation providers in Florida

Medicare billing

Part B allowed, 2024
$1,141,719
Medicare patients
669
Services billed
16,622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen6,647$209,087
Nurtec OdtRimegepant Sulfate102$169,462
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen4,060$164,798
UbrelvyUbrogepant113$156,197
RelistorMethylnaltrexone Bromide48$110,964
QuliptaAtogepant77$85,002
Xtampza ErOxycodone Myristate128$66,238
Gabapentin3,877$56,587
Pregabalin1,246$52,484
Oxycodone Hcl2,657$50,262
OxycontinOxycodone Hcl71$38,795
Morphine Sulfate ErMorphine Sulfate1,466$35,421
Naloxone Hcl490$30,893
Tramadol Hcl1,877$27,831
Tizanidine Hcl1,559$19,214

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy, Qulipta, Linzess$1,250$249,451204 claims
PfizerNurtec Odt$988$169,462102 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor$573$110,96448 claims
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca$800$80,799153 claims
Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate, Buprenorphine-Naloxone$32$37,307514 claims
Redhill Biopharma Inc.Movantik$19$10,86525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 618 physical medicine & rehabilitation providers in Florida.

Other physical medicine & rehabilitation in Ocala

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →